Showing results (251-260 of 340) with videos related to
Sort By:
Pageof 34
The American Journal of Pathology|February 1, 1993
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding proteinP Garin-Chesa, I Campbell, P E Saigo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancerB Reichman, M Markman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomyM S Wertheim, T B Hakes, A N Daghestani, et al.Cytokine|March 17, 1998
Interleukin 3 (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitroJ L Lewis, S B Marley, N M Blackett, et al.Obstetrics and Gynecology|December 1, 1994
Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infectionI Benjamin, R R Barakat, J P Curtin, et al.Cancer|April 15, 1986
Prognostic factors in adenocarcinoma of the uterine cervixP E Saigo, J M Cain, W S Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancerM Markman, T Hakes, B Reichman, et al.The Yale Journal of Biology and Medicine|July 1, 1989
Intraperitoneal therapy in the management of ovarian carcinomaM Markman, T Hakes, B Reichman, et al.Cancer|April 11, 1976
Malignant ovarian tumors in childhood: prognosis in relation to initial therapyN Wollner, P R Exelby, J M Woodruff, et al.Carcinogenesis|April 3, 1998
Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposureP Gerde, B A Muggenburg, G G Scott, et al.Pageof 34